Similarly, Kolb et al. found a marker increased by obesity-associated inflammation, ANGPTL4, which was also correlated with a poor prognosis of breast cancer patients [47]. Here, ANGPTL4 is linked to obesity due to melanocortin 4 receptor deficiency.